This Free Drug for treating COVID is Not Used Enough | Mild to Moderate COVID Treatment

#MildCOVIDTreatment #REGENCOV

Hi everyone! Welcome back this week! Let's look at COVID treatment this week. Not that everyone has a fair chance to get infected with the Delta variant, it is important to know what is available for early COVID treatment!

If you appreciate my work, you can buy me a coffee. :)
https://www.buymeacoffee.com/dr2hong

Disclaimer:

This video is Dr. Hong’s interpretation and summary of publically available scientific information
This video is not intended to serve as any advice regarding the treatment, prevention, and diagnosis of any diseases
Dr. Hong has no connections and receives no monetary compensation from any pharmaceutical companies and government.
This video is for educational purposes only.

-------------------------------
To learn more:

Worldwide Vaccine Series
https://youtube.com/playlist?list=PLk0eVd-2hM7kCpIBCOZrW78UuWilENkPR

Immunology Shot and Brief
https://youtube.com/playlist?list=PLk0eVd-2hM7ki8RUeYYOuuwUn6sBHLa2H

-------------------------------
Source References:

NIH Clinical Management Summary (Aug 25, 2021)
https://www.covid19treatmentguidelines.nih.gov/management/clinical-management/clinical-management-summary/

Therapeutic Management of Hospitalized Adults With COVID-19
https://www.covid19treatmentguidelines.nih.gov/management/clinical-management/hospitalized-adults--therapeutic-management/

Therapeutic Management of Nonhospitalized Adults With COVID-19
https://www.covid19treatmentguidelines.nih.gov/management/clinical-management/nonhospitalized-adults--therapeutic-management/

Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19

Coronavirus (COVID-19) Update: FDA Authorizes Additional Monoclonal Antibody for Treatment of COVID-19
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-monoclonal-antibody-treatment-covid-19

REGEN-COV website
https://www.regeneron.com/medicines/casirivimab-imdevimab

REGEN-COV
https://www.regencov.com/hcp/access

Washingtonpost
https://www.washingtonpost.com/health/covid-monoclonal-abbott/2021/08/19/a39a0b5e-0029-11ec-a664-4f6de3e17ff0_story.html

NBC NEWS
https://www.nbcnews.com/think/opinion/if-covid-vaccine-refusers-are-turned-away-hospitals-doctor-offices-ncna1277475

Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection
https://www.amjmed.com/article/S0002-9343(20)30673-2/fulltext

Early Outpatient Treatment of SARS-CoV-2 (COVID-19): A Comment
https://www.amjmed.com/article/S0002-9343(20)30875-5/fulltext

The Reply
https://www.amjmed.com/article/S0002-9343(20)31093-7/fulltext#relatedArticles

MERCK announcement
https://www.merck.com/news/merck-and-ridgeback-biotherapeutics-provide-update-on-progress-of-clinical-development-program-for-molnupiravir-an-investigational-oral-therapeutic-for-the-treatment-of-mild-to-moderate-covid-19/

MERCK Announcement
https://www.merck.com/news/ridgeback-biotherapeutics-and-merck-announce-preliminary-findings-from-a-phase-2a-trial-of-investigational-covid-19-therapeutic-molnupiravir/

MERCK announcement
https://www.merck.com/news/merck-announces-supply-agreement-with-u-s-government-for-molnupiravir-an-investigational-oral-antiviral-candidate-for-treatment-of-mild-to-moderate-covid-19/

Tamiflu
https://www.tamiflu.com/

Flu vs COVID-19
https://www.cdc.gov/flu/symptoms/flu-vs-covid19.htm

The Guardian article
https://www.theguardian.com/science/2021/jul/16/huge-study-supporting-ivermectin-as-covid-treatment-withdrawn-over-ethical-concerns

Ivermectin Study withdrawn
https://www.researchsquare.com/article/rs-100956/v4

covid treatmentmild to moderate covid treatmentregeneron covid treatment